WRD
WeRide Inc.
Software - Infrastructure
Market Cap$2.40B
5Y Perf.-50.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
WRD vs RBOT
Revenue, margins, valuation, and 5-year total return — side by side.
RBOT
Vicarious Surgical Inc.
Medical - Devices
Market Cap$3M
5Y Perf.-93.8%
WRD vs RBOT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | WRD | RBOT |
|---|---|---|
| Industry | Software - Infrastructure | Medical - Devices |
| Market Cap | $2.40B | $3M |
| Revenue (TTM) | $361M | $0.00 |
| Net Income (TTM) | $-2.52B | $-42M |
| Gross Margin | 30.7% | — |
| Operating Margin | -6.1% | — |
| Total Debt | $143M | $8M |
| Cash & Equiv. | $4.27B | $3M |
WRD vs RBOT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
WRD
RBOT
| Stock | Oct 24 | May 26 | Return |
|---|---|---|---|
| WeRide Inc. (WRD) | 100 | 50.0 | -50.0% |
| Vicarious Surgical … (RBOT) | 100 | 6.2 | -93.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WRD vs RBOT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: RBOT leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. WeRide Inc. is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
WRD
WeRide Inc.
The Long-Run Compounder
WRD is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- -55.3% 10Y total return vs RBOT's -99.8%
- Lower volatility, beta 2.87, Low D/E 2.0%, current ratio 13.43x
- -11.1% vs RBOT's -94.1%
Best for: long-term compounding and sleep-well-at-night
RBOT
Vicarious Surgical Inc.
The Income Pick
RBOT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.92
- EPS growth 21.2%
- Beta 1.92, current ratio 2.97x
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | RBOT | 31.5% revenue growth vs WRD's -10.1% |
| Quality / Margins | RBOT | 5.0% margin vs WRD's -7.0% |
| Stability / Safety | RBOT | Beta 1.92 vs WRD's 2.87 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | WRD | -11.1% vs RBOT's -94.1% |
| Efficiency (ROA) | WRD | -37.8% ROA vs RBOT's -164.5%, ROIC -55.7% vs -116.2% |
WRD vs RBOT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
Segment breakdown not available.
WRD vs RBOT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLWRDLAGGINGRBOT
RBOTVicarious Surgical In…
0leads
WRDWeRide Inc.
2leads
6 Total Categories
CATEGORYLEADERvs RBOTMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
—
—
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
WRD7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
WRD6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
WRD and RBOT operate at a comparable scale, with $361M and $0 in trailing revenue.
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| RevenueTrailing 12 months | $361M | $0 |
| EBITDAEarnings before interest/tax | — | -$42M |
| Net IncomeAfter-tax profit | — | -$42M |
| Free Cash FlowCash after capex | — | -$40M |
| Gross MarginGross profit ÷ Revenue | +30.7% | — |
| Operating MarginEBIT ÷ Revenue | -6.1% | — |
| Net MarginNet income ÷ Revenue | -7.0% | — |
| FCF MarginFCF ÷ Revenue | -188.0% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +58.1% |
Insufficient data to determine a leader in this category.
Valuation Metrics
Evenly matched — WRD and RBOT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| Market CapShares × price | $2.4B | $3M |
| Enterprise ValueMkt cap + debt − cash | $1.8B | $8M |
| Trailing P/EPrice ÷ TTM EPS | -5.50x | -0.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 45.14x | — |
| Price / BookPrice ÷ Book value/share | 1.96x | 0.30x |
| Price / FCFMarket cap ÷ FCF | — | — |
Evenly matched — WRD and RBOT each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
WRD leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
WRD delivers a -125.4% return on equity — every $100 of shareholder capital generates $-125 in annual profit, vs $-3 for RBOT. WRD carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to RBOT's 0.79x. On the Piotroski fundamental quality scale (0–9), WRD scores 2/9 vs RBOT's 1/9, reflecting mixed financial health.
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| ROE (TTM)Return on equity | -125.4% | -3.3% |
| ROA (TTM)Return on assets | -37.8% | -164.5% |
| ROICReturn on invested capital | -55.7% | -116.2% |
| ROCEReturn on capital employed | -104.7% | -134.6% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 1 |
| Debt / EquityFinancial leverage | 0.02x | 0.79x |
| Net DebtTotal debt minus cash | -$4.1B | $5M |
| Cash & Equiv.Liquid assets | $4.3B | $3M |
| Total DebtShort + long-term debt | $143M | $8M |
| Interest CoverageEBIT ÷ Interest expense | -780.14x | — |
WRD leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
WRD leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WRD five years ago would be worth $4,465 today (with dividends reinvested), compared to $16 for RBOT. Over the past 12 months, WRD leads with a -11.1% total return vs RBOT's -94.1%. The 3-year compound annual growth rate (CAGR) favors WRD at -23.6% vs RBOT's -80.2% — a key indicator of consistent wealth creation.
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| YTD ReturnYear-to-date | -21.3% | -80.6% |
| 1-Year ReturnPast 12 months | -11.1% | -94.1% |
| 3-Year ReturnCumulative with dividends | -55.3% | -99.2% |
| 5-Year ReturnCumulative with dividends | -55.3% | -99.8% |
| 10-Year ReturnCumulative with dividends | -55.3% | -99.8% |
| CAGR (3Y)Annualised 3-year return | -23.6% | -80.2% |
WRD leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — WRD and RBOT each lead in 1 of 2 comparable metrics.
Risk & Volatility
RBOT is the less volatile stock with a 1.92 beta — it tends to amplify market swings less than WRD's 2.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WRD currently trades 58.9% from its 52-week high vs RBOT's 3.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.87x | 1.92x |
| 52-Week HighHighest price in past year | $12.55 | $13.75 |
| 52-Week LowLowest price in past year | $6.00 | $0.35 |
| % of 52W HighCurrent price vs 52-week peak | +58.9% | +3.6% |
| RSI (14)Momentum oscillator 0–100 | 50.1 | 30.0 |
| Avg Volume (50D)Average daily shares traded | 4.3M | 24K |
Evenly matched — WRD and RBOT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | WRDWeRide Inc. | RBOTVicarious Surgica… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | $17.50 | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
WRD leads in 2 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 2 categories are tied.
Best OverallWeRide Inc. (WRD)Leads 2 of 6 categories
Loading custom metrics...
WRD vs RBOT: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — WRD or RBOT?
Over the past 5 years, WeRide Inc.
(WRD) delivered a total return of -55. 3%, compared to -99. 8% for Vicarious Surgical Inc. (RBOT). Over 10 years, the gap is even starker: WRD returned -55. 3% versus RBOT's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — WRD or RBOT?
By beta (market sensitivity over 5 years), Vicarious Surgical Inc.
(RBOT) is the lower-risk stock at 1. 92β versus WeRide Inc. 's 2. 87β — meaning WRD is approximately 49% more volatile than RBOT relative to the S&P 500. On balance sheet safety, WeRide Inc. (WRD) carries a lower debt/equity ratio of 2% versus 79% for Vicarious Surgical Inc. — giving it more financial flexibility in a downturn.
03Which is growing faster — WRD or RBOT?
On earnings-per-share growth, the picture is similar: Vicarious Surgical Inc.
grew EPS 21. 2% year-over-year, compared to -24. 0% for WeRide Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — WRD or RBOT?
Vicarious Surgical Inc.
(RBOT) is the more profitable company, earning 0. 0% net margin versus -696. 9% for WeRide Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RBOT leads at 0. 0% versus -605. 1% for WRD. At the gross margin level — before operating expenses — WRD leads at 30. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — WRD or RBOT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is WRD or RBOT better for a retirement portfolio?
For long-horizon retirement investors, Vicarious Surgical Inc.
(RBOT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. WeRide Inc. (WRD) carries a higher beta of 2. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RBOT: -99. 8%, WRD: -55. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between WRD and RBOT?
These companies operate in different sectors (WRD (Technology) and RBOT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.